{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T14:30:12Z","timestamp":1781620212789,"version":"3.54.5"},"reference-count":30,"publisher":"American Society for Microbiology","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin. Vaccine Immunol."],"published-print":{"date-parts":[[2014,11]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p><jats:named-content content-type=\"genus-species\">Neisseria meningitidis<\/jats:named-content>causes disease only in humans. An important mechanism underlying this host specificity is the ability of the organism to resist complement by recruiting the complement downregulator factor H (FH) to the bacterial surface. In previous studies, binding of FH to one of the major meningococcal FH ligands, factor H binding protein (FHbp), was reported to be specific for human FH. Here we report that sera from 23 of 73 rhesus macaques (32%) tested had high FH binding to FHbp. Similar to human FH, binding of macaque FH to the meningococcal cell surface inhibited the complement alternative pathway by decreasing deposition of C3b. FH contains 20 domains (or short consensus repeats), with domains 6 and 7 being responsible for binding of human FH to FHbp. DNA sequence analyses of FH domains 6 and 7 from macaques with high or low FH binding showed a polymorphism at residue 352 in domain 6, with Tyr being associated with high binding and His with low binding. A recombinant macaque FH 6,7\/Fc fragment with Tyr352 showed higher binding to FHbp than the corresponding fragment with His352. In previous studies in human FH transgenic mice, binding of FH to FHbp vaccines decreased protective antibody responses, and mutant FHbp vaccines with decreased FH binding elicited serum antibodies with greater protective activity. Thus, macaques with high FH binding to FHbp represent an attractive nonhuman primate model to investigate further the effects of FH binding on the immunogenicity of FHbp vaccines.<\/jats:p>","DOI":"10.1128\/cvi.00517-14","type":"journal-article","created":{"date-parts":[[2014,9,4]],"date-time":"2014-09-04T15:03:08Z","timestamp":1409842988000},"page":"1505-1511","source":"Crossref","is-referenced-by-count":19,"title":["Heterogeneity in Rhesus Macaque Complement Factor H Binding to Meningococcal Factor H Binding Protein (FHbp) Informs Selection of Primates To Assess Immunogenicity of FHbp-Based Vaccines"],"prefix":"10.1128","volume":"21","author":[{"given":"Peter T.","family":"Beernink","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jutamas","family":"Shaughnessy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Stefek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Ram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan M.","family":"Granoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","published-online":{"date-parts":[[2014,9,3]]},"reference":[{"key":"key20180919073748_B1","doi-asserted-by":"publisher","first-page":"B87","DOI":"10.1016\/j.vaccine.2012.01.033","article-title":"The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: immunological, functional and structural characterization of the antigens","volume":"30","author":"Serruto","year":"2012","journal-title":"Vaccine"},{"key":"key20180919073748_B2","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1128\/MMBR.00056-12","article-title":"Role of factor H binding protein in Neisseria meningitidis virulence and its potential as a vaccine candidate to broadly protect against meningococcal disease","volume":"77","author":"McNeil","year":"2013","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"key20180919073748_B3","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1084\/jem.20021911","article-title":"Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870","volume":"197","author":"Masignani","year":"2003","journal-title":"J. Exp. Med."},{"key":"key20180919073748_B4","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1128\/IAI.72.4.2088-2100.2004","article-title":"Vaccine potential of the Neisseria meningitidis 2086 lipoprotein","volume":"72","author":"Fletcher","year":"2004","journal-title":"Infect. Immun."},{"key":"key20180919073748_B5","doi-asserted-by":"publisher","first-page":"501","DOI":"10.4049\/jimmunol.177.1.501","article-title":"The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance","volume":"177","author":"Madico","year":"2006","journal-title":"J. Immunol."},{"key":"key20180919073748_B6","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1128\/IAI.01191-08","article-title":"Binding of complement factor H (fH) to Neisseria meningitidis is specific for human fH and inhibits complement activation by rat and rabbit sera","volume":"77","author":"Granoff","year":"2009","journal-title":"Infect. Immun."},{"key":"key20180919073748_B7","doi-asserted-by":"publisher","first-page":"3606","DOI":"10.4049\/jimmunol.1003470","article-title":"A meningococcal factor H binding protein mutant that eliminates factor H binding enhances protective antibody responses to vaccination","volume":"186","author":"Beernink","year":"2011","journal-title":"J. Immunol."},{"key":"key20180919073748_B8","doi-asserted-by":"publisher","first-page":"e1002688","DOI":"10.1371\/journal.ppat.1002688","article-title":"The effect of human factor H on immunogenicity of meningococcal native outer membrane vesicle vaccines with over-expressed factor H binding protein","volume":"8","author":"Beernink","year":"2012","journal-title":"PLoS Pathog."},{"key":"key20180919073748_B9","doi-asserted-by":"publisher","first-page":"5451","DOI":"10.1016\/j.vaccine.2013.08.099","article-title":"Meningococcal factor H-binding protein vaccines with decreased binding to human complement factor H have enhanced immunogenicity in human factor H transgenic mice","volume":"31","author":"Rossi","year":"2013","journal-title":"Vaccine"},{"key":"key20180919073748_B10","doi-asserted-by":"publisher","first-page":"e01625","DOI":"10.1128\/mBio.01625-14","article-title":"Human Factor H (FH) impairs protective meningococcal anti-FHbp antibody responses and the antibodies enhance FH binding","volume":"5","author":"Costa","year":"2014","journal-title":"mBio"},{"key":"key20180919073748_B11","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1128\/CVI.00260-13","article-title":"Does binding of complement factor H to the meningococcal vaccine antigen, factor H binding protein, decrease protective serum antibody responses?","volume":"20","author":"Granoff","year":"2013","journal-title":"Clin. Vaccine Immunol."},{"key":"key20180919073748_B12","first-page":"321","article-title":"Improving safety and efficacy of meningococcal vaccines","volume":"9","author":"Granoff","year":"2014","journal-title":"Microbe"},{"key":"key20180919073748_B13","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1126\/science.1139247","article-title":"Evolutionary and biomedical insights from the rhesus macaque genome","volume":"316","author":"Gibbs","year":"2007","journal-title":"Science"},{"key":"key20180919073748_B14","first-page":"91","article-title":"Comparison of immunity to pathogens in humans, chimpanzees and macaques","volume-title":"Chimpanzees in biomedical and behavioral research: assessing the necessity","author":"Haigwood","year":"2011"},{"key":"key20180919073748_B15","doi-asserted-by":"publisher","first-page":"4728","DOI":"10.1016\/j.vaccine.2011.04.095","article-title":"Immunogenicity of a meningococcal native outer membrane vesicle vaccine with attenuated endotoxin and over-expressed factor H binding protein in infant rhesus monkeys","volume":"29","author":"Koeberling","year":"2011","journal-title":"Vaccine"},{"key":"key20180919073748_B16","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1002\/ajp.20811","article-title":"Genetic characterization of specific pathogen-free rhesus macaque (Macaca mulatta) populations at the California National Primate Research Center (CNPRC)","volume":"72","author":"Kanthaswamy","year":"2010","journal-title":"Am. J. Primatol."},{"key":"key20180919073748_B17","first-page":"598","article-title":"Population genetic statistics from rhesus macaques (Macaca mulatta) in three different housing configurations at the California National Primate Research Center","volume":"49","author":"Kanthaswamy","year":"2010","journal-title":"J. Am. Assoc. Lab. Anim. Sci."},{"key":"key20180919073748_B18","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1093\/infdis\/jit239","article-title":"Importance of inhibition of binding of complement factor H for serum bactericidal antibody responses to meningococcal factor H-binding protein vaccines","volume":"208","author":"Konar","year":"2013","journal-title":"J. Infect. Dis."},{"key":"key20180919073748_B19","doi-asserted-by":"publisher","first-page":"3751","DOI":"10.1128\/IAI.05182-11","article-title":"Complement-mediated bactericidal activity of anti-factor H binding protein monoclonal antibodies against the meningococcus relies upon blocking factor H binding","volume":"79","author":"Giuntini","year":"2011","journal-title":"Infect. Immun."},{"key":"key20180919073748_B20","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1385\/1-59259-148-5:81","article-title":"Outer membrane protein vesicle vaccines for meningococcal disease","volume-title":"Meningococcal vaccines: methods and protocols","author":"Frasch","year":"2001"},{"key":"key20180919073748_B21","doi-asserted-by":"publisher","first-page":"e00339","DOI":"10.1128\/mBio.00339-13","article-title":"Factor H-dependent alternative pathway inhibition mediated by porin B contributes to virulence of Neisseria meningitidis","volume":"4","author":"Lewis","year":"2013","journal-title":"mBio"},{"key":"key20180919073748_B22","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00444-14","article-title":"A fusion protein comprising factor H domains 6 and 7 and human IgG1 Fc as an anti-bacterial immunotherapeutic","author":"Shaughnessy","year":"2014","journal-title":"Clin. Vaccine Immunol."},{"key":"key20180919073748_B23","doi-asserted-by":"publisher","first-page":"2574","DOI":"10.1128\/IAI.01517-14","article-title":"Inhibition of the alternative pathway of nonhuman infant complement by porin B2 contributes to virulence of Neisseria meningitidis in the infant rat model","volume":"82","author":"Lewis","year":"2014","journal-title":"Infect. Immun."},{"key":"key20180919073748_B24","doi-asserted-by":"publisher","first-page":"6465","DOI":"10.4049\/jimmunol.175.10.6465","article-title":"Pharmacological inhibition of endotoxin responses is achieved by targeting the TLR4 coreceptor, MD-2","volume":"175","author":"Visintin","year":"2005","journal-title":"J. Immunol."},{"key":"key20180919073748_B25","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1128\/IAI.01183-13","article-title":"Nonfunctional variant 3 factor H binding proteins as meningococcal vaccine candidates","volume":"82","author":"van der Veen","year":"2014","journal-title":"Infect. Immun."},{"key":"key20180919073748_B26","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1038\/nature07769","article-title":"Neisseria meningitidis recruits factor H using protein mimicry of host carbohydrates","volume":"458","author":"Schneider","year":"2009","journal-title":"Nature"},{"key":"key20180919073748_B27","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1159\/000356513","article-title":"The role of complement in age-related macular degeneration: heparan sulphate, a ZIP code for complement factor H?","volume":"6","author":"Langford-Smith","year":"2014","journal-title":"J. Innate Immun."},{"key":"key20180919073748_B28","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1128\/IAI.05604-11","article-title":"Enhanced bacteremia in human factor H transgenic rats infected by Neisseria meningitidis","volume":"80","author":"Vu","year":"2012","journal-title":"Infect. Immun."},{"key":"key20180919073748_B29","doi-asserted-by":"publisher","first-page":"e1002981","DOI":"10.1371\/journal.ppat.1002981","article-title":"Design and evaluation of meningococcal vaccines through structure-based modification of host and pathogen molecules","volume":"8","author":"Johnson","year":"2012","journal-title":"PLoS Pathog."},{"key":"key20180919073748_B30","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1073\/pnas.1217420110","article-title":"Neisseria infection of rhesus macaques as a model to study colonization, transmission, persistence, and horizontal gene transfer","volume":"110","author":"Weyand","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Clinical and Vaccine Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1128\/CVI.00517-14","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T20:49:56Z","timestamp":1627591796000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CVI.00517-14"}},"subtitle":[],"editor":[{"given":"D. L.","family":"Burns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,9,3]]},"references-count":30,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2014,10,29]]},"published-print":{"date-parts":[[2014,11]]}},"alternative-id":["10.1128\/CVI.00517-14"],"URL":"https:\/\/doi.org\/10.1128\/cvi.00517-14","relation":{},"ISSN":["1556-6811","1556-679X"],"issn-type":[{"value":"1556-6811","type":"print"},{"value":"1556-679X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,3]]}}}